Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease
Open Access
- 17 October 2025
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 411, 120551
Abstract
No abstract availableKeywords
This publication has 132 references indexed in Scilit:
- Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2022
- Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug AdministrationHepatology, 2020
- Trends in Liver Disease Etiology Among Adults Awaiting Liver Transplantation in the United States, 2014-2019JAMA Network Open, 2020
- Metabolic health in normal-weight and obese individualsDiabetologia, 2018
- Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysisHepatology Communications, 2018
- Triglyceride Metabolism in the LiverComprehensive Physiology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Glycated Hemoglobin Measurement and Prediction of Cardiovascular DiseaseJAMA, 2014
- Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitusDiabetologia, 2012